He succeeds Kingsley Chin, MD, who served as founder and CEO of KICVentures for 15 years. Dr. Chin will focus on expanding the company’s healthcare portfolio.
For the past three years Mr. Yamada operated as chief business officer of AxioMed.
He has 25 years of experience in the medical device industry, including executive leadership roles at Integra LifeSciences, NanFUSE Biologics and Arthrex, according to his LinkedIn profile.
Mr. Yamada played a chief role in the commercialization of LDR’s Mobi-C cervical disc, which Zimmer Biomet acquired for $1.1 billion in 2016.
More articles on devices:
8 of the biggest whistleblower cases in spine, orthopedics this year
Outpatient joint replacements to ‘skyrocket over next 10 years,’ says Dr. Richard Berger
Centinel Spine founder leaves to grow other business; Steven Murray named CEO
